- Home
- IAF vs ATRA Comparison
IAF vs ATRA Comparison
Compare IAF & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IAF | ATRA |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.6M | 129.4M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | IAF | ATRA |
|---|---|---|
| Price | $13.15 | $4.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 90.4K | ★ 587.9K |
| Earning Date | 01-01-0001 | 03-06-2026 |
| Dividend Yield | ★ 11.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | N/A | ★ $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.35 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $3.60 | $4.25 |
| 52 Week High | $4.59 | $19.15 |
Technical Indicators
Market Signals| Indicator | IAF | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 69.29 | 23.94 |
| Support Level | $12.85 | $4.25 |
| Resistance Level | $13.35 | $5.19 |
| Average True Range (ATR) | 0.16 | 1.62 |
| MACD | -0.01 | -1.53 |
| Stochastic Oscillator | 84.15 | 2.54 |
Price Performance
Historical ComparisonAbout IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).